Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL- 3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus- induced tumors

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7773-7782

  Chen, Wei ^a,c   Qin, Huilian ^a   Chesebro, Bruce ^b   Cheever, Martin A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS DNA;

AMINO ACID SEQUENCE; ARTICLE; CARCINOGENESIS; CYTOTOXIC T LYMPHOCYTE; ERYTHROLEUKEMIA; FRIEND LEUKEMIA VIRUS; GENETIC CODE; IMMUNIZATION; IMMUNOGENICITY; LEUKEMIA; MOLONEY LEUKEMIA ONCOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAUSCHER LEUKEMIA VIRUS; VACCINIA VIRUS; VIRION;

EID: 0029824275     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7773-7782.1996     Document Type: Article

References (40)

1. Bacik, I., J. H. Cox, R. Anderson, J. W. Yewdell, and J. R. Bennink. 1994. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide. J. Immunol. 152:381-387.
2. Berenson, J. R., A. B. Einstein, Jr., and A. Fefer. 1975. Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells. J. Immunol. 115:234-238.
3. Cheever, M., P. Greenberg, and A. Fefer. 1980. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors. J. Immunol. 125:711-714.
4. Cheever, M. A., M. L. Disis, H. Bernhard, J. R. Gralow, S. L. Hand, E. S. Huseby, H. L. Qin, M. Takahashi, and W. Chen. 1995. Immunity to oncogenic proteins. Immunol. Rev. 145:33-59.
5. Chen, W., V. A. Reese, and M. A. Cheever. 1990. Adoptively transferred antigen-specific T cells can be grown and maintained in large numbers in vivo for extended periods of time by intermittent restimulation with specific antigen plus 1L-2. J. Immunol. 144:3659-3666.
6. Chesebro, B., W. Britt, L. Evans, K. Wehrly, J. Nishio, and M. Cloyd. 1983. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134-148.
7. Chesebro, B., and K. Wehrly. 1976. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity. J. Exp. Med. 143:85-99.
8. Chesebro, B., K. Wehrly, M. Cloyd, W. Britt, J. Partis, J. Collins, and J. Nishio. 1981. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens. Virology 112:131-144.
9. Corbin, A., A. C. Prats, J. L. Darlix, and M. Sitbon. 1994. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J. Virol. 68:3857-3867.
10. Dickson, C., R. Eisenman, H. Fan, E. Hunter, and N. Teich. 1982 Protein biosynthesis and assembly, p. 513-648. In R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses. Molecular biology of tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
11. Earl, P. L., B. Moss, R. P. Morrison, K. Wehrly, J. Nishio, and B. Chesebro. 1986. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science 234:728-731.
12. Falk, K., O. Rotzschke, S. Stevanovíc, G. Jung, and H. G. Rammensee, 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (London) 351:290-296.
13. Feltkamp, M. C., M. P. Vierboom, W. M. Kast, and C. J. Melief. 1994. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol. Immunol. 31:1391-1401.
14. Gilbert, M. J., S. R. Riddell, C. R. Li, and P. D. Greenberg. 1993. Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J. Virol. 67:3461-3469.
15. Glynn, J. P., J. L. McCoy, and A. Fefer. 1968. Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors. Cancer Res. 28:434-439.
16. Greenberg, P. D. 1991. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49:281-355.
17. Hasenkrug, K. J., D. M. Brooks, and B. Chesebro. 1995. Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proc. Natl. Acad. Sci. USA 92:10492-10495.
18. Heemels, M. T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides, Annu. Rev. Biochem. 64:463-491.
19. 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. J. Natl. Cancer Inst. 53:1103-1111.
20. Holt, C. A., K. Osorio, and F. Lilly. 1986. Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities. J. Exp. Med. 164:211-226.
21. Iwashiro, M., T. Kondo, T. Shimizu, H. Yamagishi, K. Takahashi, Y. Matsubayashi, T. Masuda, A. Otaka, N. Fujii, A. Ishimoto, A. Ishimoto, M. Miyazawa, M. N. Robertson, B. Chesebro, and K. Kuribayashi. 1993. Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells. J. Virol. 67:4533-4542.
22. Khanna, R., S. R. Burrows, M. G. Kurilla, C. A. Jacob, I. S. Misko, T. B. Sculley, E. Kieff, and D. J. Moss. 1992. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 176:169-176.
23. Klarnet, J. P., D. E. Kern, K. Okuno, C. Holt, F. Lilly, and P. D. Greenberg. 1989. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens. J. Exp. Med. 169:457-467.
24. Kondo, T., H. Uenishi, T. Shimizu, T. Hirama, M. Iwashiro, K. Kuribayashi, H. Tamamura, N. Fujii, R. Fujisawa, M. Miyazawa, and H. Yamagishi. 1995. A single retroviral Gag precursor signal peptide recognized by FBL-3 tumor-specific cytotoxic T lymphocytes. J. Virol. 69:6735-6741.
25. Ljunggren, H-G., N. Slam, C. Öhlén, J. Neefjes, P. Höglund, M.-T. Heemels, J. Bastin, T. Schumacher, A. Townsend, K. Kärre, and H. Ploegh. 1990 Empty MHC class I molecules come out in the cold. Nature (London) 346:476-480.
26. Melief, C. J., and W. M. Kast. 1994. Prospects for T cell immunotherapy of tumours by vaccination with immunodominant and subdominant peptides. Ciba Found. Symp. 187:97-104.
27. Miyazawa, M., J. Nishio, and B. Chesebro. 1992. Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene. J. Virol. 66:4497-4507.
28. Murray, R. J., M. G. Kurilla, J. M. Brooks, W. A. Thomas, M. Rowe, E. Kieff, and A. B. Rickinson. 1992. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 176:157-168.
29. Prats, A. C., G. De-Billy, P. Wang, and J. L. Darlix. 1989. CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus. J. Mol. Biol. 205:363-372.
30. Robertson, M. N., G. J. Spangrude, K. Hasenkrug, L. Perry, J. Nishio, K. Wehrly, and B. Chesebro. 1992. Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J. Virol. 66:3271-3277.
31. Rotzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H. G. Rammensee. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (London) 348:252-254.
32. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891-2894.
33. Ruan, K. S., and F. Lilly. 1991. Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic T lymphocytes. Virology 181:91-100.
34. Shimizu, T., H. Uenishi, Y. Teramura, M. Iwashiro, K. Kuribayashi, H. Tamamura, N. Fujii, and H. Yamagishi. 1994. Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells. J. Virol. 68:7704-7708.
35. Sijts, A. J. M., F. Ossendorp, E. A. M. Mengedé, P. J. van den Elsen, and C. J. M. Melief. 1995. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes. J. Immunol. 152:106-116.
36. Siliciano, R. F., and M. J. Soloski. 1995. MHC class I-restricted processing of transmembrane proteins: mechanism and biologic significance. J. Immunol. 155:1-5.
37. Smith, G. L., B. R. Murphy, and B. Moss. 1983. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc. Natl. Acad. Sci. USA 80:7155-7159.
38. Townsend, A., C. Ohlén, J. Bastin, H. G. Ljunggren, L. Foster, and K. Karre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature (London) 340:443-448.
39. White, H. D., D. A. Roeder, and W. R. Green. 1994. An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes. J. Virol. 68:897-904.
40. Zweerink, H. J., M. C. Gammon, U. Utz, S. Y. Sauma, T. Harrer, J. C. Hawking, R. P. Johnson, A. Sirotina, J. D. Hermes, B. D. Walker, et al. 1993. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J. Immunol. 150:1763-1771.